GLOBAL VETERINARY MEDICINES MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • GLOBAL VETERINARY MEDICINES MARKET FORECAST 2019-2028

GLOBAL VETERINARY MEDICINES MARKET FORECAST 2019-2028

The global veterinary medicines market is projected to register a CAGR of 4.53% between 2019 and 2028, and is anticipated to generate revenue of $34108.0 million by 2028. Parasiticide is a type of veterinary drug, used for the prevention or elimination of external and internal parasites such as ticks, fleas, and worms. Apart from drugs, vaccines are also used in the treatment of numerous medical situations in animals.

GLOBAL VETERINARY MEDICINES MARKET FORECAST 2019-2028

Global Veterinary Medicines Market by Animal Type (Companion Animals, Livestock Animals) by Distribution Channel (Retail Veterinary Pharmacies, Veterinary Hospital Pharmacies) by Route of Administration (Parenteral Route, Oral Route, Topical Route) by Product (Drugs (Anti-infective, Anti-inflammatory, Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives(Antibiotics, Amino Acids)) and by Geography.

Request free sample

The global veterinary medicines market is projected to register a CAGR of 4.53% between 2019 and 2028, and is anticipated to generate revenue of $34108.0 million by 2028.

Parasiticide is a type of veterinary drug, used for the prevention or elimination of external and internal parasites such as ticks, fleas, and worms. Apart from drugs, vaccines are also used in the treatment of numerous medical situations in animals.
Global Veterinary Medicines Market

To learn more about this report, request a free sample copy

Key factors propelling the global veterinary medicines market growth:

  • Surging livestock population
  • Increasing animal healthcare expenditure
    • According to the American Pet Products Association, in the United States, the total animal health care expenditure increased from $90.5 billion in 2018 to $95.7 billion in 2019.
    • In addition, this number is projected to increase to $99.0 billion in 2020, thereby driving the overall market growth.
  • Growing pet ownership
  • Rising prevalence of several diseases in animals

Major factors restraining market growth:

  • Stringent regulations with respect to veterinary medicines
  • Side effects associated with veterinary vaccines on human and animal health
  • Lack of basic infrastructure facilities for the veterinary animals in the underdeveloped economies
  • High cost of vaccinations
    • The costs of vaccinations have surged, as many indirect costs are associated with the production of vaccines, such as personnel costs for ordering, inventory, and many other factors.
    • Apart from these factors, high storage costs are hindering the market growth.
  • Rising popularity of vegetarianism and veganism in North America

The report scope of the global veterinary medicines market includes the segmentation analysis of animal type, distribution channel, route of administration, and product. These segments are further classified to provide a detailed analysis of the studied market.

Market by Product:

  • Drugs
    • Drugs are the dominant segment in the veterinary medicines market by product.
    • Veterinary drugs in animals are used for treating various medical conditions.
    • For instance, anti-infective drugs are used in animals to treat infections caused by various micro-organisms.
    • Drugs are segmented into Anti-infective, Anti-inflammatory, and Parasiticide.
  • Vaccines
  • Medicated Feed Additives

Geographically, the global veterinary medicines market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific veterinary medicines market is expected to record the highest CAGR by 2028.
    • The market is driven by the high investments in R&D by global market players and constant efforts for commercialization of veterinary medicines at moderately lower prices.
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global veterinary medicines market are:

  • Boehringer Ingelheim Animal Health Gmbh
  • Ceva Sante Animale
  • Elanco
  • Merck & Co
  • Virbac SA
  • Others

Key strategies adopted by some of the veterinary medicines companies:

In September 2020, Click Therapeutics and Boehringer Ingelheim collaborated to develop and commercialize CT-155, a novel prescription digital therapeutic, for supplementing the schizophrenia treatment. Also, in August 2020, Elanco announced that it closed the acquisition of Bayer Animal Health. The transaction was treasured at $ 6.89 billion.

Key findings of the global veterinary medicines market:

  • There is a rising awareness with regard to animal healthcare.
  • Drugs contribute majorly in terms of revenue in the product segment.
  • The parenteral route is the prominent route of administration in terms of market share and CAGR.
  • Livestock animals harbored the largest market share in the animal type segment in 2019.

 

Frequently Asked Questions & Answers (FAQs):

  • What are the new technology developments associated with the veterinary medicines market?

     A: Modified DNA vaccines represent an emerging technology due to its swift accessibility, along with its well-controlled production. Also, the expansion of commercially-viable formulations of mRNA are likely to offer several opportunities for the veterinary medicine market.

  • How is the adoption of companion animals beneficial for market growth?

     A: The increasing adoption of companion animals provides an opportunity for market growth, due to increasing awareness on animal healthcare and people, becoming more sensitive toward animals and the pain they suffer during injuries, sickness, recoveries, and the aftereffects of sickness related to animal physiology.

  • What is the impact of the strategic initiatives by the various organization for the growth of the market?

     A: Innovation in veterinary medicine is driven through partnering, collaboration, and strategic alliance activities of research institutes and manufacturers, which is anticipated to benefit the market in the near future.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • SURGING LIVESTOCK POPULATION
      • INCREASING ANIMAL HEALTHCARE EXPENDITURE
      • GROWING PET OWNERSHIP
      • RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
    •    KEY RESTRAINTS
      • STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • LACK OF BASIC INFRASTRUCTURE FACILITIES FOR THE VETERINARY ANIMALS IN THE UNDERDEVELOPED ECONOMIES
      • HIGH COST OF VACCINATIONS
      • RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  3. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  4. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  5. MARKET BY PRODUCT
    •    DRUGS
      • ANTI-INFECTIVE
      • ANTI-INFLAMMATORY
      • PARASITICIDE
    •    VACCINES
      • INACTIVATED VACCINES
      • ATTENUATED VACCINES
      • RECOMBINANT VACCINES
    •    MEDICATED FEED ADDITIVES
      • ANTIBIOTICS
      • AMINO ACIDS
  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • POLAND
      • BELGIUM
      • REST OF EUROPE
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • AUSTRALIA & NEW ZEALAND
      • INDIA
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • ARCHER DANIELS MIDLAND
    • BIOGENESIS BAGO SA
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • DECHRA PHARMACEUTICALS PLC
    • ELANCO
    • EVONIK INDUSTRIES AG (RAG STIFTUNG)
    • HESTER BIOSCIENCES LIMITED
    • INDIAN IMMUNOLOGICALS LIMITED
    • KINDRED BIOSCIENCES
    • MERCK & CO
    • NEOGEN CORPORATION
    • VETOQUINOL (SOPARFIN SCA)
    • VIRBAC SA
    • ZOETIS

TABLE LIST

TABLE 1: MARKET SNAPSHOT – VETERINARY MEDICINES

TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)

TABLE 3: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: GLOBAL COMPANION ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: GLOBAL COMPANION ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 10: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 11: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 13: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 14: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 15: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 16: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 17: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 19: GLOBAL ORAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 20: GLOBAL ORAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 21: GLOBAL TOPICAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 22: GLOBAL TOPICAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 23: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 24: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 25: GLOBAL DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 26: GLOBAL DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 27: GLOBAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 28: GLOBAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 29: GLOBAL VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 30: GLOBAL VACCINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 31: GLOBAL VACCINES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 32: GLOBAL VACCINES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 33: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 34: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 35: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 36: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 37: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 38: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 39: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 40: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 41: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 42: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 43: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 44: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 45: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 46: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURE LIST          

FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019

FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 10: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 11: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 12: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 14: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 15: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 16: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019

FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)

FIGURE 18: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)

FIGURE 19: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)

FIGURE 20: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)

FIGURE 21: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 22: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 23: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 24: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 25: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)

FIGURE 26: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)

FIGURE 27: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 29: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 30: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 31: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 32: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 35: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 36: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 37: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 38: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 39: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 40: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 41: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 42: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 43: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 44: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 45: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 46: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 47: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 48: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 49: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 50: REST OF WORLD VETERINARY MEDICINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 51: LATIN AMERICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

  1. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  2. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  3. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  4. MARKET BY PRODUCT
    •    DRUGS
      • ANTI-INFECTIVE
      • ANTI-INFLAMMATORY
      • PARASITICIDE
    •    VACCINES
      • INACTIVATED VACCINES
      • ATTENUATED VACCINES
      • RECOMBINANT VACCINES
    •    MEDICATED FEED ADDITIVES
      • ANTIBIOTICS
      • AMINO ACIDS
  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • POLAND
      • BELGIUM
      • REST OF EUROPE
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • AUSTRALIA & NEW ZEALAND
      • INDIA
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now